Huadong Medicine Co Ltd (000963.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Distributors · China · ISIN CNE0000011S1

Price
26.62 CNY
Market cap
46.69 bn CNY
P/E (2025)
13.68
P/S (2025)
1.07
Dividend yield
3.49 %
Net margin
7.83 %
Return on equity (ROE)
13.76 %
Return on assets (ROA)
8.75 %

Huadong Medicine Co Ltd financials

Fiscal year20242025
Revenue41.91 bn CNY43.61 bn CNY
Gross profit13.90 bn CNY14.11 bn CNY
Operating income4.32 bn CNY4.49 bn CNY
EBIT4.34 bn CNY4.10 bn CNY
Net income3.51 bn CNY3.41 bn CNY
Diluted EPS – continuing operations2.00 CNY1.95 CNY

Full history since 1996, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Huadong Medicine Co Ltd

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides formulation filling, technical, transportation and warehousing services. The company has strategic collaboration with Heidelberg Pharma AG to jointly develop Antibody Drug Conjugates (ADCs). Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.

Huadong Medicine Co Ltd stock (000963.SZ): P/E, revenue, dividend | finmetric